Search Results 591-600 of 16852 for Amphotericin B
B., Ph.D. Vijay Shah, M.D.. More about research at Mayo Clinic.
Gococo-Benore DA, Parent E, Sharma A, Accurso J, Yang M, Kendi AT, Sonbol B, Halfdanarson TR, Starr JS. Hepatotoxicity from peptide receptor radionuclide ...
... B) of CA-4948 in patients with RR NHL with and without myeloid differentiation primary response 88 (MYD88) mutations. During Part B, patients will be ...
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies. Rochester, Minn. The purpose of this study is to find out ...
... B. Maselli, M.D., a gastroenterologist at Mayo Clinic in Rochester, Minnesota, with specialized training in metabolic and bariatric endoscopy. GFMA ...
The purpose of this study is to provide access to CTL019 through Managed Access Program (MAP) for acute lymphoblastic leukemia (ALL) or diffuse large b-cell ...
This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...
Palmer B, Petrik M. Psychological Evaluation and Management of Chronic Pancreatitis Gastroenterology Clinics of North America. 2022; 51(4):799-813. Li T, Petrik ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.